Scinai Immunotherapeutics (SCNI) Interest & Investment Income (2014 - 2022)
Scinai Immunotherapeutics (SCNI) reported Interest & Investment Income of $2.8 million for Q4 2022, up 1999.32% on a YoY basis from $132090.7 in Q4 2021, and up 1052.92% sequentially from -$291000.0 in Q3 2022.
Scinai Immunotherapeutics (SCNI) Interest & Investment Income (2014 - 2022) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 9 years of Interest & Investment Income data on file, last reported at $2.8 million in Q4 2022.
- For the quarter ending Q4 2022, Interest & Investment Income rose 1999.32% year-over-year to $2.8 million; the trailing twelve-month figure through Dec 2022 stood at $4.4 million (up 142.61% YoY), and the FY2023 full-year result was $9000.0, down 99.83% from the prior year.
- Interest & Investment Income improved to $2.8 million in Q4 2022, from -$291000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $16.5 million in Q1 2020 to a low of -$9.7 million in Q2 2019.
- A 5-year average of $1.7 million and a median of $368000.0 in 2021 frame the typical range for Interest & Investment Income.
- Peak annual rise in Interest & Investment Income reached 1999.32% in 2022, while the deepest fall reached 114.7% in 2022.
- Tracing SCNI's Interest & Investment Income over 5 years: stood at $1.5 million in 2018, then plunged by 88.36% to $169000.0 in 2019, then slumped by 804.73% to -$1.2 million in 2020, then surged by 87.74% to -$146000.0 in 2021, then jumped by 1999.32% to $2.8 million in 2022.
- Business Quant data shows SCNI's Interest & Investment Income at $2.8 million in Q4 2022, -$291000.0 in Q3 2022, and $1.6 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Scinai Immunotherapeutics | 3.54 Bn | 424.15 Mn | -1.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 2.77 Mn |
| Sep 30, 2022 | -291,000.00 |
| Jun 30, 2022 | 1.57 Mn |
| Mar 31, 2022 | 382,000.00 |
| Dec 31, 2021 | -146,000.00 |
| Sep 30, 2021 | 1.98 Mn |
| Jun 30, 2021 | -360,000.00 |
| Mar 31, 2021 | 354,000.00 |
| Dec 31, 2020 | -1.19 Mn |
| Mar 31, 2020 | 16.50 Mn |
| Sep 30, 2019 | 169,000.00 |
| Jun 30, 2019 | -9.75 Mn |
| Mar 31, 2019 | 9.75 Mn |
| Sep 30, 2018 | 1.45 Mn |
| Mar 31, 2017 | 2,000.00 |
| Mar 31, 2016 | 393,000.00 |
| Dec 31, 2015 | 1.78 Mn |
| Sep 30, 2015 | -1.54 Mn |
| Jun 30, 2015 | 3,000.00 |
| Mar 31, 2015 | 5,000.00 |